Safety, Tolerability, and Pharmacokinetics of the β‐Site Amyloid Precursor Protein‐Cleaving Enzyme 1 Inhibitor Verubecestat ( MK ‐8931) in Healthy Elderly Male and Female Subjects-Reference-Cited by-同舟云学术

Safety, Tolerability, and Pharmacokinetics of the β‐Site Amyloid Precursor Protein‐Cleaving Enzyme 1 Inhibitor Verubecestat ( MK ‐8931) in Healthy Elderly Male and Female Subjects

Published:2019-06-19 Issue:5 Volume:12 Page:545-555
ISSN:1752-8054
Container-title:Clinical and Translational Science
language:en
Short-container-title:Clin Transl Sci

Author:

Forman Mark¹,Palcza John¹,Tseng Jack¹²,Stone Julie A.¹,Walker Brittany¹,Swearingen Dennis³⁴,Troyer Matthew D.¹⁵,Dockendorf Marissa F.¹

Affiliation:

1. Merck & Co., Inc. Kenilworth New Jersey USA

2. Purdue Pharma Stamford Connecticut USA

3. Celerion Tempe Arizona USA

4. Banner Health Phoenix Arizona USA

5. Denali Therapies South San Francisco California USA

Publisher

Wiley

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine,General Neuroscience

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cts.12645

Reference22 articles.

1. 2017 Alzheimer's disease facts and figures

2. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016

3. Stages of the Pathologic Process in Alzheimer Disease: Age Categories From 1 to 100 Years

4. The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to Therapeutics

5. A Hundred Years of Alzheimer's Disease Research

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Brain macrophage senescence in glioma;Seminars in Cancer Biology;2024-09

2. BACE1 Inhibitors for Alzheimer’s Disease: Current Challenges and Future Perspectives;Journal of Alzheimer's Disease;2024-06-22

3. Amyloid Pathology Modulates the Associations of Neuropsychiatric Symptoms with Cognitive Impairments and Neurodegeneration in Non-Demented Elderly;Journal of Alzheimer's Disease;2024-01-02

4. Computationally Driven Design of Novel BACE-1 Inhibitors for Alzheimer’s Disease;2023-11-16

5. BACE1 Inhibitors for Alzheimer’s Disease: The Past, Present and Any Future?;Molecules;2022-12-12